Development of Environmentally Responsive Self-Emulsifying System Containing Copaiba Oil-Resin for Leishmaniasis Oral Treatment

Leishmaniasis is a disease caused by protozoa species of the <i>Leishmania</i> genus, and the current treatments face several difficulties and obstacles. Most anti-leishmanial drugs are administered intravenously, showing many side effects and drug resistance. The discovery of new anti-l...

Full description

Saved in:
Bibliographic Details
Main Authors: Mariana Carla de Oliveira (Author), Rodolfo Bento Balbinot (Author), Mônica Villa Nova (Author), Renato Sonchini Gonçalves (Author), Danielle Lazarin Bidóia (Author), Wilker Caetano (Author), Celso Vataru Nakamura (Author), Marcos Luciano Bruschi (Author)
Format: Book
Published: MDPI AG, 2023-08-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Leishmaniasis is a disease caused by protozoa species of the <i>Leishmania</i> genus, and the current treatments face several difficulties and obstacles. Most anti-leishmanial drugs are administered intravenously, showing many side effects and drug resistance. The discovery of new anti-leishmanial compounds and the development of new pharmaceutical systems for more efficient and safer treatments are necessary. Copaiba oil-resin (CO) has been shown to be a promising natural compound against leishmaniasis. However, CO displays poor aqueous solubility and bioavailability. Self-emulsifying drug delivery systems (SEDDS) can provide platforms for release of hydrophobic compounds in the gastrointestinal tract, improving their aqueous solubilization, absorption and bioavailability. Therefore, the present work aimed to develop SEDDS containing CO and Soluplus<sup>®</sup> surfactant for the oral treatment of leishmaniasis. The design of the systems was accomplished using ternary phase diagrams. Emulsification and dispersion time tests were used to investigate the emulsification process in gastric and intestinal environments. The formulations were nanostructured and improved the CO solubilization. Their in vitro antiproliferative activity against promastigote forms of <i>L. amazonensis</i> and <i>L. infantum</i>, and low in vitro cytotoxicity against macrophages were also observed. More studies are necessary to determine effectiveness of SOL in these systems, which can be candidates for further pharmacokinetics and in vivo investigations.
Item Description:10.3390/pharmaceutics15082127
1999-4923